SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IMNR - Immune Response
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Steve Smith who wrote (559)6/23/1998 10:32:00 PM
From: jake burns  Read Replies (1) of 1510
 
Steve: on the Yahoo board, someone mentioned that Dr. Carlo, IMNR's president, used the phrase "investment grade data" to describe what will be presented at Geneva on July 2 and 3. I understand Dr. Carlo to be conservative and not given to exaggeration. If true about the data being "investment grade," then IMNR will be (as Bob Dehaven said on a recent Yahoo post) "better than sex." Who can figure where the market will take this thing. Heck, I thought we'd be 16-18 dollars on the morning following the agph deal....What happened? We receded to 13 before hitting 16 dollars today, 8 trading days later. My best guess is 18-24 dollars a week after geneva (July 10). I would be flabbergasted if we did not hold this 16 dollar price through that date. Supposedly, technicians claim there's no resistance through 24.50 for this stock....I'm not a technician (Manny and Bob are)...just a fundamentalist. Also, don't forget that AGPH paid 17 dollars for their shares ($2 million for 118,000 shares). If we get great data at geneva (to make fda approval extremely likely), we'll really be in good shape as wall street heretofore has been reluctant to give IMNR anything....it's almost as if remune must be approved first. If the data is great, you'll have money being bet on remune's approval...and we're in the 20s.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News